Sonoma Pharmaceuticals (SNOA) News Today $2.63 +0.08 (+3.14%) (As of 12/20/2024 05:23 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Spectral AI (NASDAQ:MDAI) vs. Sonoma Pharmaceuticals (NASDAQ:SNOA) Head-To-Head AnalysisDecember 19 at 3:03 AM | americanbankingnews.comSonoma Pharmaceuticals, Inc. (O8Z.F)November 22, 2024 | uk.finance.yahoo.comSonoma Pharmaceuticals announces relaunch of dermatology, eye care linesNovember 22, 2024 | markets.businessinsider.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United StatesNovember 21, 2024 | finanznachrichten.deSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn-based Wound Care HydrogelNovember 12, 2024 | finanznachrichten.deFDA grants Sonoma 510(k) approval for Microdacyn HydrogelNovember 12, 2024 | markets.businessinsider.comSonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor ConferencesOctober 22, 2024 | stockhouse.comSonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above 200 Day Moving Average - Should You Sell?October 11, 2024 | marketbeat.comSonoma Pharmaceuticals (NASDAQ:SNOA) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comSonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above Two Hundred Day Moving Average of $0.33Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200-Day Moving Average of $0.33September 20, 2024 | marketbeat.comShort Interest in Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Drops By 65.4%Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA - Get Free Report) was the target of a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 130,300 shares, a decline of 65.4% from the August 15th total of 376,200 shares. Currently, 13.0% of the shares of the company are short sold. Based on an average trading volume of 192,400 shares, the days-to-cover ratio is currently 0.7 days.September 12, 2024 | marketbeat.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product LineSeptember 11, 2024 | finanznachrichten.deSonoma Pharmaceuticals (NASDAQ:SNOA) Stock Passes Above 200 Day Moving Average of $0.23Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200 Day Moving Average of $0.23August 31, 2024 | marketbeat.comSonoma Pharmaceuticals Inc (O8Z3.MU)August 30, 2024 | uk.finance.yahoo.comWhy Sonoma Pharmaceuticals (SNOA) Stock Is MovingAugust 28, 2024 | benzinga.comSonoma Pharmaceuticals First Quarter 2025 Earnings: Misses ExpectationsAugust 12, 2024 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial ResultsAugust 9, 2024 | finanznachrichten.deSNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025August 9, 2024 | investorplace.comSonoma Pharmaceuticals, Inc. (SNOA)July 20, 2024 | finance.yahoo.comSNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024June 17, 2024 | investorplace.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement StoresMay 9, 2024 | finanznachrichten.deSonoma Pharmaceuticals Inc.April 30, 2024 | money.usnews.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United StatesApril 9, 2024 | finanznachrichten.deSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor ConferencesMarch 28, 2024 | finanznachrichten.deSonoma Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagFebruary 10, 2024 | finance.yahoo.comSonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial ResultsFebruary 8, 2024 | finance.yahoo.comSonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily UseJanuary 23, 2024 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial ResultsNovember 13, 2023 | finanznachrichten.deSonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial ResultsNovember 13, 2023 | finance.yahoo.comSonoma Pharmaceuticals Inc SNOANovember 11, 2023 | morningstar.comSonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall ConferenceNovember 3, 2023 | finance.yahoo.comUS Stocks Mixed; Bristol Myers Posts Upbeat EarningsOctober 26, 2023 | benzinga.comCrude Oil Down 2.5%; Mastercard Posts Upbeat EarningsOctober 26, 2023 | markets.businessinsider.comDow Dips Over 100 Points; US GDP Growth Tops ExpectationsOctober 26, 2023 | benzinga.comSonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common StockOctober 26, 2023 | finance.yahoo.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62%October 24, 2023 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.62%October 24, 2023 | msn.commacOS SonomaSeptember 28, 2023 | macrumors.comNational Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn AdvancedAugust 15, 2023 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial ResultsAugust 10, 2023 | finanznachrichten.deSonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial ResultsAugust 10, 2023 | finance.yahoo.comSonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory BoardAugust 3, 2023 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial ResultsJune 22, 2023 | finanznachrichten.deSonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial ResultsJune 22, 2023 | finance.yahoo.comSonoma Pharmaceuticals Shares Soar 44% After Introducing New ProductJune 9, 2023 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European UnionJune 8, 2023 | finanznachrichten.deSonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European UnionJune 8, 2023 | finance.yahoo.comWilliams-Sonoma Could Be Headed for More TroubleMay 21, 2023 | thestreet.com8-K: Sonoma Pharmaceuticals, Inc.May 11, 2023 | marketwatch.comBenign Growth For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Underpins Its Share PriceApril 19, 2023 | finance.yahoo.com Get Sonoma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now SNOA Media Mentions By Week SNOA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNOA News Sentiment▼0.000.59▲Average Medical News Sentiment SNOA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNOA Articles This Week▼10▲SNOA Articles Average Week Get Sonoma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cara Therapeutics News Today Acurx Pharmaceuticals News Today Marinus Pharmaceuticals News Today TherapeuticsMD News Today HCW Biologics News Today AIM ImmunoTech News Today Sol-Gel Technologies News Today Aspira Women's Health News Today ImmunoPrecise Antibodies News Today Imunon News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNOA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNOA Stock Alerts